HealthcareServices

Preclinical CRO Market Outlook: Growth and Forecast Highlights 2030

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the preclinical cro market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Preclinical CRO Market expected to grow between 2026 and 2030?

The preclinical cro market size has demonstrated strong expansion in recent years. It is anticipated to grow from $6.25 billion in 2025 to $6.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. The market’s growth in prior periods can be attributed to heightened pharmaceutical R&D investments, the increasing complexity of drug development pipelines, a greater reliance on animal testing for safety validation, the expansion of biotechnology research endeavors, and stricter regulatory oversight concerning preclinical data.

The preclinical CRO market is expected to demonstrate substantial expansion in the upcoming years. It is projected to achieve a size of $9.83 billion by 2030, progressing at a compound annual growth rate (CAGR) of 9.5%. The projected increase within this period is driven by several factors, including a rising need for precision medicine research, a greater focus on developing drugs for rare diseases, the expansion of biologics and cell therapy pipelines, the increasing implementation of digital preclinical platforms, and a growth in collaborations between pharmaceutical companies and CROs. Significant patterns observed in the forecast duration involve a wider adoption of integrated preclinical study services, an escalating requirement for advanced animal model expertise, an increase in the outsourcing of early-stage drug development activities, an expansion of toxicology capabilities that conform to regulatory standards, and a heightened emphasis on study designs informed by data.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10303&type=smp

Which Drivers Are Influencing Market Acceleration In The Preclinical CRO Market?

The rising need for preclinical trials is anticipated to boost the expansion of the preclinical CRO market in the future. These trials involve any investigation of a medicine or therapy for a specific ailment prior to its administration to human participants. Preclinical studies frequently encompass new medical devices, prescribed drugs, and diagnostic tools, aiming primarily to determine a safe initial dosage for human trials and assess the product’s potential toxicity. Their role in drug development is crucial, with their significance growing due to increased focus on the safety and effectiveness of new medications. For instance, in February 2024, according to IQVIA, a US-based company serving the combined industries of health information technology and clinical research reports, clinical development productivity rose in 2023, where a total of 69 novel active substances (NASs) were launched globally in 2023, 6 more than the prior year, and including 24 first-in-class launches in the U.S. Consequently, the increasing demand for preclinical trials is propelling the growth of the preclinical CRO market moving forward.

What Segments Are Identified Within The Structure Of The Preclinical CRO Market?

The preclinical cro market covered in this report is segmented –

1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services

2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model

3) By Animal Model: Small Animal Model, Large Animal Model

4) By Model System: In Vivo, In Vitro

5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users

Subsegments:

1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies, Pharmacodynamics Studies, Drug Metabolism Studies

2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Reproductive Toxicity Testing

3) By Compound Management: Sample Management, Inventory Management, Formulation Services

4) By Chemistry: Medicinal Chemistry, Analytical Chemistry, Synthetic Chemistry

5) By Safety Pharmacology: Cardiovascular Safety Studies, Central Nervous System Safety Studies, Respiratory Safety Studies

6) By Other Services: Regulatory Consulting, Project Management, Data Management Services

Which Innovation Trends Are Advancing Developments Within The Preclinical CRO Market?

Leading companies in the preclinical CRO market are embracing new technologies to maintain their standing, such as a disease biology knowledge graph, which enhances target identification and drug discovery in pharmaceutical research. This disease biology knowledge graph provides a structured, comprehensive representation of the relationships between genes, proteins, pathways, and disease phenotypes, designed to integrate diverse biological data. It empowers researchers to systematically explore disease mechanisms, pinpoint potential therapeutic targets, and accelerate drug discovery by offering a holistic map of disease biology. For instance, in February 2023, BenchSci, a Canada-based AI solutions company for preclinical R&D, launched ASCEND, an end-to-end SaaS (software as a service) platform intended for preclinical drug discovery. This method aims to expedite preclinical phase drug development pipelines by providing biological insights into the fundamental underpinnings of disease. ASCEND extracts experimental data from secure internal and public external sources using BenchSci’s machine-learning technology. The platform compares experimental results utilizing curated ontology datasets. As a result, the software can generate an evidence-based map of the biological processes underlying various diseases.

Which Major Industry Participants Are Leading The Preclinical CRO Market Growth?

Major companies operating in the preclinical cro market are Eurofins Scientific SE, WuXi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Laboratory Corporation Of America Holdings, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Altasciences Company Inc, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd, ICON plc, Kunming Biomed International Ltd, PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc, Syngene International Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Preclinical CRO Market?

North America was the largest region in the preclinical CRO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical cro market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Preclinical CRO Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10303&type=smp

Browse Through More Reports Similar to the Global Preclinical CRO Market 2026, By The Business Research Company

Veterinary Cro And Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Healthcare Cro Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

Crm Bpo Market Report 2026

https://www.thebusinessresearchcompany.com/report/crm-bpo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795